AR030048A1 - Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- AR030048A1 AR030048A1 ARP010100496A ARP010100496A AR030048A1 AR 030048 A1 AR030048 A1 AR 030048A1 AR P010100496 A ARP010100496 A AR P010100496A AR P010100496 A ARP010100496 A AR P010100496A AR 030048 A1 AR030048 A1 AR 030048A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- pharmaceutical compositions
- compositions containing
- diabetes
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Derivados heterocíclicos de formula 1 en la cual A, B, D, X, R1, R2, R3 y R4 son tal como se definen en la descripcion, sus enantiomeros y diastereoisomeros así como sus sales de adicion con un ácido o con una base farmacéuticamente aceptables; procedimiento para prepararlos y composiciones farmacéuticas que los contienen. Los derivados heterocíclicos de formula 1 son utiles para el tratamiento y/o la profilaxis de la hiperglucemias, de las dislipidemias y más particularmente en el tratamiento de las diabetes no insulinodependientes del tipo II, de la resistencia a la insulina, de la tolerancia a la glucosa, de los desordenes relacionados con el síndrome X, de las enfermedades arteriales coronarias y otras enfermedades cardiovasculares, de las enfermedades renales, de las retinopatías, de los desordenes relacionados con la activacion de las células endoteliales, de la psoriasis, del síndrome poliquístico de ovario, de la demencia, de la osteoporosis, de las enfermedades inflamatorias intestinales, de las distrofias miotonicas, de las pancreatitis, de la arterioesclerosis, del xantoma, pero también en el tratamiento o la prevencion de la diabetes de tipo I, de la obesidad, de la regulacion del apetito, de la anorexia, de la bulimia, de la anorexia nerviosa, así como de las patologías cancerosas y en especial de los cánceres hormonodependientes tales como el cáncer de pecho y el cáncer de colon, y como inhibidores de angiogénesis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0001289A FR2804431A1 (fr) | 2000-02-02 | 2000-02-02 | Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030048A1 true AR030048A1 (es) | 2003-08-13 |
Family
ID=8846564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100496A AR030048A1 (es) | 2000-02-02 | 2001-02-02 | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (26)
Country | Link |
---|---|
US (1) | US6919362B2 (es) |
EP (1) | EP1252150B1 (es) |
JP (1) | JP2003521541A (es) |
KR (1) | KR100495365B1 (es) |
CN (1) | CN1211374C (es) |
AR (1) | AR030048A1 (es) |
AT (1) | ATE242223T1 (es) |
AU (1) | AU775281B2 (es) |
BR (1) | BR0108046A (es) |
CA (1) | CA2398674A1 (es) |
CZ (1) | CZ20022646A3 (es) |
DE (1) | DE60100335T2 (es) |
DK (1) | DK1252150T3 (es) |
EA (1) | EA004676B1 (es) |
ES (1) | ES2201029T3 (es) |
FR (1) | FR2804431A1 (es) |
HK (1) | HK1052007A1 (es) |
HU (1) | HUP0204354A3 (es) |
MX (1) | MXPA02007402A (es) |
NO (1) | NO20023662L (es) |
NZ (1) | NZ520260A (es) |
PL (1) | PL356911A1 (es) |
PT (1) | PT1252150E (es) |
SK (1) | SK11162002A3 (es) |
WO (1) | WO2001057002A1 (es) |
ZA (1) | ZA200205599B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2845601B1 (fr) * | 2002-10-11 | 2005-07-08 | Servier Lab | Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent |
FR2845998A1 (fr) * | 2002-10-18 | 2004-04-23 | Servier Lab | Nouveaux composes benzoxazoles ou oxazolopyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
US20050004133A1 (en) * | 2003-06-05 | 2005-01-06 | Makings Lewis R. | Modulators of VR1 receptor |
FR2858321B1 (fr) * | 2003-07-28 | 2006-01-20 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2868313B1 (fr) * | 2004-03-31 | 2008-08-15 | Servier Lab | Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent |
FR2881137B1 (fr) * | 2005-01-27 | 2007-03-02 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE102005026808A1 (de) | 2005-06-09 | 2006-12-14 | Sanofi-Aventis Deutschland Gmbh | Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
FR2894965B1 (fr) * | 2005-12-20 | 2008-01-25 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2898125B1 (fr) * | 2006-03-06 | 2008-06-13 | Servier Lab | Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2903404B1 (fr) * | 2006-07-10 | 2008-08-22 | Servier Lab | Nouveaux derives tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ZA200902382B (en) | 2006-10-19 | 2010-08-25 | Signal Pharm Llc | Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
US20100158829A1 (en) * | 2008-12-24 | 2010-06-24 | Conopco, Inc., D/B/A Unilever | Method and Composition for Color Modulation |
DE102009012314A1 (de) | 2009-03-09 | 2010-09-16 | Bayer Schering Pharma Aktiengesellschaft | Oxo-heterocyclisch substituierte Alkylcarbonsäuren und ihre Verwendung |
CN105073728A (zh) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4116090A1 (de) * | 1991-05-17 | 1992-11-19 | Basf Ag | (alpha)-phenylacrylsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen und schadpilzen |
DE19546918A1 (de) * | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
-
2000
- 2000-02-02 FR FR0001289A patent/FR2804431A1/fr active Pending
-
2001
- 2001-02-01 NZ NZ520260A patent/NZ520260A/en unknown
- 2001-02-01 AT AT01904021T patent/ATE242223T1/de not_active IP Right Cessation
- 2001-02-01 ES ES01904021T patent/ES2201029T3/es not_active Expired - Lifetime
- 2001-02-01 KR KR10-2002-7009942A patent/KR100495365B1/ko not_active IP Right Cessation
- 2001-02-01 PT PT01904021T patent/PT1252150E/pt unknown
- 2001-02-01 MX MXPA02007402A patent/MXPA02007402A/es active IP Right Grant
- 2001-02-01 WO PCT/FR2001/000304 patent/WO2001057002A1/fr active IP Right Grant
- 2001-02-01 JP JP2001556852A patent/JP2003521541A/ja active Pending
- 2001-02-01 DE DE60100335T patent/DE60100335T2/de not_active Expired - Fee Related
- 2001-02-01 CN CNB018043399A patent/CN1211374C/zh not_active Expired - Fee Related
- 2001-02-01 SK SK1116-2002A patent/SK11162002A3/sk unknown
- 2001-02-01 PL PL01356911A patent/PL356911A1/xx not_active Application Discontinuation
- 2001-02-01 HU HU0204354A patent/HUP0204354A3/hu unknown
- 2001-02-01 US US10/203,113 patent/US6919362B2/en not_active Expired - Fee Related
- 2001-02-01 CA CA002398674A patent/CA2398674A1/fr not_active Abandoned
- 2001-02-01 EA EA200200810A patent/EA004676B1/ru not_active IP Right Cessation
- 2001-02-01 BR BR0108046-6A patent/BR0108046A/pt not_active IP Right Cessation
- 2001-02-01 DK DK01904021T patent/DK1252150T3/da active
- 2001-02-01 CZ CZ20022646A patent/CZ20022646A3/cs unknown
- 2001-02-01 AU AU31953/01A patent/AU775281B2/en not_active Ceased
- 2001-02-01 EP EP01904021A patent/EP1252150B1/fr not_active Expired - Lifetime
- 2001-02-02 AR ARP010100496A patent/AR030048A1/es unknown
-
2002
- 2002-07-12 ZA ZA200205599A patent/ZA200205599B/en unknown
- 2002-08-01 NO NO20023662A patent/NO20023662L/no unknown
-
2003
- 2003-06-16 HK HK03104267A patent/HK1052007A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR030048A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
ATE493388T1 (de) | Acylierte 1,2,3,4-tetrahydronaphthylamine und deren verwendung als pharmazeutika | |
ES2861931T3 (es) | Nuevos análogos de epicatequina y polifenoles relacionados | |
Bacharaju et al. | Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents | |
RU2006126651A (ru) | Новые производные фенилаланина | |
JP5021549B2 (ja) | 癌細胞の処理のための組成物及びその合成方法 | |
GT200600340A (es) | Inhibidores macrociclicos del virus de hepatitis c | |
CN103054869A (zh) | 含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用 | |
CN1150197C (zh) | 作为细胞毒性抗肿瘤剂的萘并噻吩和二氢苯并噻吩的衍生物 | |
Maddila et al. | New class of pyrimidinesulfamoyl containing pyrazole and pyrrole derivatives and their antioxidant activity | |
EA016552B1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
RU2007106880A (ru) | Производные азасахара, ингибиторы гепараназ, способ их получения, содержащие их композиции, их применение | |
CN103113386B (zh) | 氮杂环取代二氢青蒿素衍生物及其应用 | |
Huang et al. | Cerium (IV) ammonium nitrate (CAN)-mediated regioselective synthesis and anticancer activity of 6-substituted 5, 8-dimethoxy-1, 4-naphthoquinone | |
US20120190646A1 (en) | Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer | |
AR050648A1 (es) | Derivados de alcaloides cuaternarios, composiciones farmaceuticas que los contienen y su uso en el tratamiento de disfunciones metabolicas, inmunologicas y cancer | |
FR2459239A1 (fr) | Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique | |
ECSP045291A (es) | Preparación de ácido n1-(2'-piridil)-1,2-propanodiamino sulfámico y su uso en la síntesis de piperazinas biológicamente activas | |
Bai et al. | Design, synthesis and cytotoxic activities of novel β-amino alcohol derivatives | |
Lavanya et al. | Synthesis and antioxidant activity of 1, 4-[bis (3-arylmethanesulfonyl pyrrolyl and pyrazolyl)] benzenes | |
JP4958263B2 (ja) | 有機発光性化合物及びその化合物を含有する発光層 | |
AR036876A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
Jin et al. | Synthesis and antitumor activities of resveratrol derivatives on cervical cancer Hela cells | |
US7084133B2 (en) | Dicarba-closo-dodecaborane derivatives | |
JP2007063176A (ja) | 分岐型ポリエーテル骨格を有するカーボナート誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |